Trial Profile
Drug Use Investigation for Oral Rotarix(R) (Safety Investigation of Vaccination for Rotavirus Gastroenteritis)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2023
Price :
$35
*
At a glance
- Drugs Rotavirus vaccine (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- Acronyms SMILER
- Sponsors GlaxoSmithKline; GSK
- 31 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Aug 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Mar 2016 to 1 Sep 2016.
- 26 Jul 2013 Planned End Date changed from 1 Aug 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.